Longitudinal, disease-level data are used to analyze the impact of pharmaceutical innovation on longevity (mean age at … death), hospital utilization, and medical expenditure in Greece during the period 1995 - 2010. The estimates indicate that … pharmaceutical innovation increased mean age at death by 0.87 years (10.4 months) - about 44% of the total increase in longevity …

This paper presents an econometric analysis of the effect of changes in the quantity and type of pharmaceuticals … prescribed by physicians in outpatient visits on rates of hospitalization, surgical procedure, mortality, and related variables … changes in inpatient care utilization and mortality during the period 1980-92. The estimates indicate that the number of …

We analyze the association that pharmaceutical innovation had with premature mortality from all diseases in Switzerland … had larger subsequent declines in premature mortality and hospitalization. Pharmaceutical innovation is measured by the … ignore the reduction in hospital utilization associated with previous pharmaceutical innovation, a rough estimate of the cost …

predict a hospital load and mortality, neither in Belgium nor in Sweden. On the contrary, Lock down (Belgium) or Shut down … asymptote, we assume an overload of hospital capacity and excess mortality …This study observes the results of epidemic spread and mortality in three comparable countries in demographics and GDP …